Co-Authors
This is a "connection" page, showing publications co-authored by Cédric Annweiler and YingLiang Wu.
Connection Strength
0.497
-
Neurological, Cognitive, and Behavioral Disorders during COVID-19: The Nitric Oxide Track. J Am Geriatr Soc. 2020 09; 68(9):1922-1923.
Score: 0.222
-
Counter-regulatory 'Renin-Angiotensin' System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected Patients. Infect Disord Drug Targets. 2020; 20(4):407-408.
Score: 0.215
-
Capivasertib restricts SARS-CoV-2 cellular entry: a potential clinical application for COVID-19. Int J Biol Sci. 2021; 17(9):2348-2355.
Score: 0.059